Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT - About
Envoy Medical Inc. (COCHW)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
07/07/2025: COCHW (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
0 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
Analysis of Past Performance
Type Stock | Historic Profit -70% | Avg. Invested days 25 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 07/07/2025 |
Key Highlights
Company Size ETF | Market Capitalization 0 USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) - | Beta 2.27 | 52 Weeks Range 0.03 - 0.10 | Updated Date 06/28/2025 |
52 Weeks Range 0.03 - 0.10 | Updated Date 06/28/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) - |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) -11102.17% |
Management Effectiveness
Return on Assets (TTM) -129.07% | Return on Equity (TTM) - |
Valuation
Trailing PE - | Forward PE - | Enterprise Value - | Price to Sales(TTM) - |
Enterprise Value - | Price to Sales(TTM) - | ||
Enterprise Value to Revenue - | Enterprise Value to EBITDA - | Shares Outstanding - | Shares Floating 10658404 |
Shares Outstanding - | Shares Floating 10658404 | ||
Percent Insiders - | Percent Institutions - |
Upturn AI SWOT
Envoy Medical Inc.
Company Overview
History and Background
Envoy Medical Inc., formerly known as Soundhawk Corporation, is a hearing health company focused on developing and commercializing innovative medical devices for hearing loss. Details about its exact founding date and early milestones are limited but it has evolved focusing on fully implanted hearing solutions.
Core Business Areas
- Fully Implanted Hearing Solutions: Focuses on developing and marketing the Esteemu00ae fully implanted active middle ear implant. This includes surgical procedures, device maintenance, and audiological support.
Leadership and Structure
The leadership team includes individuals with experience in medical device development and commercialization. Specifics about the full organizational structure are not publicly available.
Top Products and Market Share
Key Offerings
- Esteemu00ae: The Esteemu00ae is a fully implanted active middle ear implant designed to provide natural sound quality and improved speech understanding. The company claims that it's the only fully implanted active middle ear implant approved by the FDA. It is difficult to determine the market share due to the nascent nature of the product. Competitors include companies focused on traditional hearing aids and cochlear implants.
Market Dynamics
Industry Overview
The hearing loss industry is growing, driven by an aging population and increased awareness of hearing health. The industry consists of hearing aid manufacturers, cochlear implant providers, and emerging companies with innovative solutions like fully implanted devices.
Positioning
Envoy Medical is positioned as an innovator with its fully implanted technology. This provides a potential advantage over traditional hearing aids and cochlear implants for certain patients due to its more natural sound experience and discreetness. However, it is a smaller company than the main competitors which present challenges in scaling production and distribution.
Total Addressable Market (TAM)
The global hearing aid market is estimated to be worth billions of dollars. Envoy Medical is targeting a subset of this market, specifically individuals with moderate to severe sensorineural hearing loss who are seeking a more discreet and natural-sounding solution. As market penetration for a novel medical technology, it is very low and is trying to increase adoption with an initial small amount of users.
Upturn SWOT Analysis
Strengths
- Unique fully implanted hearing technology (Esteemu00ae)
- FDA approved
- Potential for improved sound quality and user experience compared to traditional hearing aids.
Weaknesses
- Relatively small company
- Limited market penetration
- Dependence on a single product (Esteemu00ae)
- High cost compared to traditional hearing aids
- Requires specialized surgical expertise for implantation
Opportunities
- Expanding market for hearing loss solutions
- Increasing awareness of the benefits of fully implanted devices
- Potential for partnerships with audiologists and ENT specialists
- New product development and technological advancements
Threats
- Competition from established hearing aid manufacturers
- Reimbursement challenges from insurance providers
- Technological advancements in competing hearing solutions
- Economic downturn impacting consumer spending on healthcare
Competitors and Market Share
Key Competitors
- SONO
- GN
- WS Audiology (Private)
Competitive Landscape
Envoy Medical differentiates itself with its fully implanted design compared to traditional hearing aids. However, it faces significant competition from larger companies with established brands, distribution networks, and research and development resources.
Growth Trajectory and Initiatives
Historical Growth: Envoy Medical has focused on FDA approval and initial commercialization of the Esteem device. Significant revenue growth has not yet been achieved.
Future Projections: Future growth depends on the successful commercialization of the Esteem, increased market penetration, and expansion into new markets. Analyst estimates are not widely available due to limited coverage.
Recent Initiatives: Focus on expanding the availability of surgical training and increasing awareness among audiologists and patients.
Summary
Envoy Medical is a small, innovative company with a unique fully implanted hearing solution. Its strengths lie in its differentiated technology and potential for improved patient outcomes. However, it faces challenges related to commercialization, competition, and reimbursement. Significant revenue growth is needed for long-term success.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Envoy Medical Inc. website
- FDA website
- Market research reports (hearing aid industry)
- Industry news articles
- SEC filings
Disclaimers:
The information provided is for informational purposes only and should not be considered financial advice. Market share data is approximate. Investors should conduct their own due diligence before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Envoy Medical Inc.
Exchange NASDAQ | Headquaters White Bear Lake, MN, United States | ||
IPO Launch date 2021-04-23 | CEO & Director Mr. Brent T. Lucas Esq. | ||
Sector Healthcare | Industry Medical Devices | Full time employees 42 | Website https://www.envoymedical.com |
Full time employees 42 | Website https://www.envoymedical.com | ||
Envoy Medical, Inc., a hearing health company, focuses on providing medical technologies across the hearing loss spectrum. The company's medical technologies are designed to shift the paradigm within the hearing industry and bring providers and patients the hearing devices desire. It offers personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.